Orange Book product · Generic (ANDA)
DIVALPROEX SODIUM
DIVALPROEX SODIUM
At a glance
Mar 15, 2021
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 15, 2021
5 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
DIVALPROEX SODIUM
Strength
EQ 250MG VALPROIC ACID
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
ANDA 214462
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DIVALPROEX SODIUM
- 2002DEPAKOTE ERBrand (NDA)
NDA 021168 · ABBVIE
- 1990DEPAKOTE CPBrand (NDA)
NDA 019794 · ABBOTT
- 1989DEPAKOTEBrand (NDA)
NDA 019680 · ABBVIE
- 1984DEPAKOTEBrand (NDA)
NDA 018723 · ABBVIE
- 2025DIVALPROEX SODIUMGeneric (ANDA)
ANDA 217358 · MANKIND PHARMA
- 2024DIVALPROEX SODIUMGeneric (ANDA)
ANDA 218793 · ALEMBIC
- 2023DIVALPROEX SODIUMGeneric (ANDA)
ANDA 215527 · ANNORA PHARMA
- 2022DIVALPROEX SODIUMGeneric (ANDA)
ANDA 214643 · UNICHEM
- 2020DIVALPROEX SODIUMGeneric (ANDA)
ANDA 211505 · TEVA PHARMS USA
- 2020DIVALPROEX SODIUMGeneric (ANDA)
ANDA 213181 · AJANTA PHARMA LTD
- 2019DIVALPROEX SODIUMGeneric (ANDA)
ANDA 209286 · LUPIN
- 2015DIVALPROEX SODIUMGeneric (ANDA)
ANDA 203730 · AMNEAL PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
